SynthesisDermatology and therapy2026
Narrow Excision Margins for Diverse Histological Subtypes of Cutaneous Melanoma in Children and Adults: A Systematic Review.
Synthesis in Dermatology and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionWide local excision (WLE) is a standard component of cutaneous melanoma management, although prospective evidence supporting current margin recommendations remains limited. Surgical margins have progressively decreased. However, six randomized clinical trials comparing wider (3-5 cm) vs. narrower (1-2 cm) margins did not demonstrate significant reductions in local recurrence (LR) or survival benefits. Furthermore, wider margins are associated with increased morbidity and healthcare costs.
methodsWe systematically reviewed relevant published studies up to and including December 2025 to compare LR and survival outcomes between standard WLE and no or narrow-margin excisions. The analysis included adult and pediatric cases of superficial spreading, nodular, acral, and desmoplastic cutaneous melanoma; lentigo maligna was excluded.
resultsNo prospective studies were found comparing WLE to the omission of WLE for cutaneous melanoma. Two retrospective studies reported no significant differences in LR or overall survival (OS) in patients who did not undergo WLE (n = 453). Regarding lateral margins, 30 retrospective studies were identified. Collectively, these studies suggest that narrower margins than those currently recommended are not associated with worse LR, disease-free survival, or OS for melanoma in situ and pT1-pT3 tumors (Breslow index ≤ 4 mm). However, findings for pT4 melanomas (Breslow index > 4 mm) remain inconsistent. Analysis of deep margins (n = 5 retrospective studies) largely supported more superficial excision strategies than current guidelines. Regarding acral melanoma, seven retrospective studies were located, all of which reported that narrower and shallower margins-including the preservation of plantar fat-did not adversely affect LR or survival. Conversely, in cases of desmoplastic melanoma, two retrospective studies were found with conflicting results regarding LR. In the pediatric population, evidence remains scarce; two retrospective studies evaluating narrow excision margins revealed no adverse impact on OS.
conclusionsCurrent evidence suggests that narrower lateral margins and shallower deep excision strategies could be oncologically safe. However, the absence of an observed association with higher rates of LR or worse survival outcome should not be interpreted as proof of non-inferiority to standard WLE, given the predominance of observational data, heterogeneity across studies, and limited statistical power in smaller cohorts. High-quality prospective randomized trials are required. Ongoing randomized trials (MelMART-II, WoW, and ICEMAN) will play a key role in refining future surgical margin recommendations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.